Human Blood Component Vaccinia Virus Neutralization Assay
Authors: Laura Evgin and
John Bell,
date: 12/05/2015,
view: 7733,
Q&A: 0
[Abstract] Many therapeutic viruses, such as oncolytic viruses, vaccines, or gene therapy vectors, may be administered by the intravenous route to maximize their delivery to target tissues. Blood components, such as antibody, complement and blood cells (such as neutrophils, monocytes, T cells, B cells or platelets) may result in viral neutralization and ...